-
公开(公告)号:WO2007008627A2
公开(公告)日:2007-01-18
申请号:PCT/US2006026424
申请日:2006-07-07
Applicant: ABBOTT LAB , WENDT MICHAEL D , SHEN WANG , DICKMAN DANIEL A , DING HONG , THOMAS SHEELA A , AUGERI DAVID , ELMORE STEVEN W
Inventor: WENDT MICHAEL D , SHEN WANG , DICKMAN DANIEL A , DING HONG , THOMAS SHEELA A , AUGERI DAVID , ELMORE STEVEN W
IPC: A61K31/192 , A61P35/00 , C07C15/12
CPC classification number: C07C311/41 , C07C63/48 , C07C63/49 , C07C65/26 , C07C65/28 , C07C205/58 , C07C229/52 , C07C229/56 , C07C233/81 , C07C311/13 , C07C311/18 , C07C311/21 , C07C311/37 , C07C311/44 , C07C323/20 , C07C323/25 , C07C323/62 , C07C2601/08 , C07C2601/14 , C07C2601/18 , C07C2602/10 , C07C2603/18 , C07C2603/74 , C07D207/30 , C07D213/53 , C07D215/12 , C07D215/48 , C07D333/34
Abstract: Compounds which inhibit the activity of anti-apoptotic Mcl-1 protein, compositions containing the compounds and methods of treating diseases during which are expressed the Mcl-1 protein are disclosed.
Abstract translation: 公开了抑制抗细胞凋亡Mcl-1蛋白活性的化合物,含有该化合物的组合物和治疗疾病的方法,其表达为Mcl-1蛋白。
-
公开(公告)号:WO0224636A3
公开(公告)日:2002-09-26
申请号:PCT/US0129432
申请日:2001-09-20
Applicant: ABBOTT LAB
Inventor: MCCLELLAN WILLIAM , OOST THORSTEN , BRUNCKO MILAN , WANG XILU , AUGERI DAVID J , BAUMEISTER STEVEN A , DICKMAN DANIEL A , DING HONG , DINGES JURGEN , FESIK STEPHEN W , HAJDUK PHILIP J , KUNZER AARON R , NETTESHEIM DAVID G , PETROS ANDREW M , ROSENBERG SAUL H , SHEN WANG , THOMAS SHEELA A , WENDT MICHAEL D
IPC: A61K31/18 , A61K31/428 , A61K31/63 , A61K31/635 , A61P9/10 , A61P25/16 , A61P25/28 , A61P29/00 , A61P31/12 , A61P31/18 , A61P35/00 , A61P37/02 , C07C311/46 , C07C311/51 , C07C317/28 , C07C323/12 , C07C323/17 , C07C323/25 , C07C323/30 , C07C323/37 , C07C323/43 , C07C323/44 , C07C323/48 , C07C323/58 , C07C323/60 , C07D203/10 , C07D205/04 , C07D205/12 , C07D207/09 , C07D207/24 , C07D207/40 , C07D207/404 , C07D209/08 , C07D209/52 , C07D209/54 , C07D209/96 , C07D211/14 , C07D211/44 , C07D211/70 , C07D211/74 , C07D213/56 , C07D213/61 , C07D213/64 , C07D213/69 , C07D213/70 , C07D213/71 , C07D215/14 , C07D215/22 , C07D215/227 , C07D215/38 , C07D215/48 , C07D217/04 , C07D221/20 , C07D231/12 , C07D233/60 , C07D235/08 , C07D235/26 , C07D241/08 , C07D241/16 , C07D249/04 , C07D263/32 , C07D263/56 , C07D263/58 , C07D277/62 , C07D277/64 , C07D295/13 , C07D295/155 , C07D295/16 , C07D295/185 , C07D295/20 , C07D295/205 , C07D295/215 , C07D295/26 , C07D307/14 , C07D317/54 , C07D333/28 , C07D333/68 , C07D333/70 , C07D401/06 , C07D401/12 , C07D405/04 , C07D405/06 , C07D417/12 , C07D451/02 , C07D491/107 , C07D295/14 , C07D317/58
CPC classification number: C07D207/404 , C07C311/51 , C07C317/28 , C07C323/12 , C07C323/17 , C07C323/25 , C07C323/30 , C07C323/37 , C07C323/58 , C07C323/60 , C07C2601/08 , C07C2601/14 , C07C2601/16 , C07C2601/18 , C07C2602/08 , C07C2602/10 , C07C2602/28 , C07C2602/42 , C07C2602/44 , C07C2603/74 , C07D203/10 , C07D205/12 , C07D207/24 , C07D209/08 , C07D209/96 , C07D211/44 , C07D211/70 , C07D211/74 , C07D213/61 , C07D213/70 , C07D213/71 , C07D215/14 , C07D215/227 , C07D215/48 , C07D217/04 , C07D221/20 , C07D231/12 , C07D235/08 , C07D235/26 , C07D241/16 , C07D249/04 , C07D263/56 , C07D263/58 , C07D277/62 , C07D277/64 , C07D295/13 , C07D295/155 , C07D295/185 , C07D295/205 , C07D295/215 , C07D295/26 , C07D307/14 , C07D317/54 , C07D333/28 , C07D333/68 , C07D401/06 , C07D401/12 , C07D405/04 , C07D417/12 , C07D451/02
Abstract: N-Benzoyl arylsulfonamides having the formula (I) are BCL-Xl inhibitors and are useful for promoting apoptosis. Also disclosed are BCL-Xl inhibiting compositions and methods of promoting apoptosis in a mammal.
Abstract translation: 具有式(I)的N-苯甲酰基芳基磺酰胺是BCL-X1抑制剂,可用于促进细胞凋亡。 还公开了BCL-X1抑制组合物和促进哺乳动物细胞凋亡的方法。
-
公开(公告)号:HK1115055A1
公开(公告)日:2008-11-21
申请号:HK08104997
申请日:2008-05-05
Applicant: ABBOTT LAB
Inventor: WENDT MICHAEL D , SHEN WANG , DICKMAN DANIEL A , DING HONG , THOMAS SHEELA A , AUGERI DAVID , ELMORE STEVEN W
IPC: A61K20060101 , A61P20060101 , C07C20060101
Abstract: The present invention relates to biaryl carboxylic acid compounds which inhibit the activity of anti-apoptotic Mcl-1 protein, compositions containing these compounds and methods of treating diseases which express the Mcl-1 protein.
-
公开(公告)号:DE60117157D1
公开(公告)日:2006-04-20
申请号:DE60117157
申请日:2001-09-20
Applicant: ABBOTT LAB
Inventor: MCCLELLAN WILLIAM , OOST THORSTEN , BRUNCKO MILAN , WANG XILU , AUGERI J , BAUMEISTER A , DICKMAN A , DING HONG , DINGES JURGEN , FESIK W , HAJDUK J , KUNZER R , NETTESHEIM G , PETROS M , ROSENBERG H , SHEN WANG , THOMAS A , WENDT D
IPC: C07C311/51 , A61K31/18 , A61K31/428 , A61K31/63 , A61K31/635 , A61P9/10 , A61P25/16 , A61P25/28 , A61P29/00 , A61P31/12 , A61P31/18 , A61P35/00 , A61P37/02 , C07C311/46 , C07C317/28 , C07C323/12 , C07C323/17 , C07C323/25 , C07C323/30 , C07C323/37 , C07C323/43 , C07C323/44 , C07C323/48 , C07C323/58 , C07C323/60 , C07D203/10 , C07D205/04 , C07D205/12 , C07D207/09 , C07D207/24 , C07D207/40 , C07D207/404 , C07D209/08 , C07D209/52 , C07D209/54 , C07D209/96 , C07D211/14 , C07D211/44 , C07D211/70 , C07D211/74 , C07D213/56 , C07D213/61 , C07D213/64 , C07D213/69 , C07D213/70 , C07D213/71 , C07D215/14 , C07D215/22 , C07D215/227 , C07D215/38 , C07D215/48 , C07D217/04 , C07D221/20 , C07D231/12 , C07D233/60 , C07D235/08 , C07D235/26 , C07D241/08 , C07D241/16 , C07D249/04 , C07D263/32 , C07D263/56 , C07D263/58 , C07D277/62 , C07D277/64 , C07D295/13 , C07D295/155 , C07D295/16 , C07D295/185 , C07D295/20 , C07D295/205 , C07D295/215 , C07D295/26 , C07D307/14 , C07D317/54 , C07D333/28 , C07D333/68 , C07D333/70 , C07D401/06 , C07D401/12 , C07D405/04 , C07D405/06 , C07D417/12 , C07D451/02 , C07D491/107
-
公开(公告)号:HK1058031A1
公开(公告)日:2004-04-30
申请号:HK03108723
申请日:2003-11-28
Applicant: ABBOTT LAB
Inventor: MCCLELLAN WILLIAM , OOST THORSTEN , BRUNCKO MILAN , WANG XILU , AUGERI DAVID J , BAUMEISTER STEVEN A , DICKMAN DANIEL A , DING HONG , DINGES JURGEN , FESIK STEPHEN W , HAJDUK PHILIP J , KUNZER AARON R , NETTESHEIM DAVID G , PETROS ANDREW M , ROSENBERG SAUL H , SHEN WANG , THOMAS SHEELA A , WENDT MICHAEL A
IPC: C07C20060101 , A61K31/18 , A61K31/428 , A61K31/63 , A61K31/635 , A61P9/10 , A61P25/16 , A61P25/28 , A61P29/00 , A61P31/12 , A61P31/18 , A61P35/00 , A61P37/02 , C07C311/46 , C07C311/51 , C07C317/28 , C07C323/12 , C07C323/17 , C07C323/25 , C07C323/30 , C07C323/37 , C07C323/43 , C07C323/44 , C07C323/48 , C07C323/58 , C07C323/60 , C07D20060101 , C07D203/10 , C07D205/04 , C07D205/12 , C07D207/09 , C07D207/24 , C07D207/40 , C07D207/404 , C07D209/08 , C07D209/52 , C07D209/54 , C07D209/96 , C07D211/14 , C07D211/44 , C07D211/70 , C07D211/74 , C07D213/56 , C07D213/61 , C07D213/64 , C07D213/69 , C07D213/70 , C07D213/71 , C07D215/14 , C07D215/22 , C07D215/227 , C07D215/38 , C07D215/48 , C07D217/04 , C07D221/20 , C07D231/12 , C07D233/60 , C07D235/08 , C07D235/26 , C07D241/08 , C07D241/16 , C07D249/04 , C07D263/32 , C07D263/56 , C07D263/58 , C07D277/62 , C07D277/64 , C07D295/13 , C07D295/155 , C07D295/16 , C07D295/185 , C07D295/20 , C07D295/205 , C07D295/215 , C07D295/26 , C07D307/14 , C07D317/54 , C07D333/28 , C07D333/68 , C07D333/70 , C07D401/06 , C07D401/12 , C07D405/04 , C07D405/06 , C07D417/12 , C07D451/02 , C07D491/107
-
公开(公告)号:DE69615674D1
公开(公告)日:2001-11-08
申请号:DE69615674
申请日:1996-04-18
Applicant: ABBOTT LAB
Inventor: ARENDSEN L , BAKER R , FAKHOURY A , FUNG L , GARVEY S , MCCLELLAN J , O'CONNOR J , PRASAD N , ROCKWAY W , ROSENBERG H , STEIN H , SHEN WANG , STOUT M , SULLIVAN M , AUGERI J
IPC: A61K31/195 , A61K31/215 , A61K31/38 , A61K31/381 , A61K31/41 , A61K31/4245 , A61K31/433 , A61P3/06 , A61P9/00 , A61P9/08 , A61P31/04 , A61P35/00 , A61P43/00 , C07C233/58 , C07C233/59 , C07C233/60 , C07C235/40 , C07C235/82 , C07D271/06 , C07D271/10 , C07D285/10 , C07D333/20 , A61K31/19 , A61K31/16
Abstract: The present invention provides a compound of formula (II) or a pharmaceutically acceptable salt thereof, which is useful for inhibiting protein farnesyltransferase and the farnesylation of the oncogene protein Ras, processes for the preparation of the compounds of the invention in addition to intermediates useful in these processes, a pharmaceutical composition, and to methods of using such compounds.
-
公开(公告)号:AT177420T
公开(公告)日:1999-03-15
申请号:AT94931987
申请日:1994-10-20
Applicant: ABBOTT LAB
Inventor: BAKER WILLIAM R , ROCKWAY TODD W , DONNER B GREGORY , SHEN WANG , ROSENBERG SAUL H , FAKHOURY STEPHEN A , O'CONNOR STEPHEN J , STOUT DAVID M , FUNG ANTHONY K L , GARVEY DAVID S , PRASAD RAJNANDAN , SULLIVAN GERARD M
IPC: C12N9/99 , A61K31/195 , A61K31/215 , A61K31/34 , A61K31/341 , A61K31/357 , A61K31/36 , A61K31/38 , A61K31/381 , A61K31/40 , A61K31/41 , A61K31/42 , A61K31/421 , A61K31/4245 , A61K31/44 , A61K31/4409 , A61K31/4418 , A61P3/06 , A61P7/00 , A61P9/10 , A61P31/04 , A61P43/00 , C07C69/52 , C07C69/74 , C07C231/02 , C07C233/19 , C07C233/58 , C07C233/59 , C07C233/60 , C07C233/61 , C07C233/62 , C07C233/63 , C07C235/36 , C07C235/40 , C07C237/24 , C07C245/14 , C07C251/42 , C07C259/08 , C07C275/26 , C07C311/51 , C07C323/40 , C07C323/46 , C07C327/20 , C07C327/36 , C07C327/38 , C07D207/325 , C07D213/40 , C07D257/04 , C07D257/06 , C07D263/24 , C07D271/06 , C07D271/10 , C07D277/20 , C07D277/34 , C07D285/16 , C07D285/18 , C07D307/42 , C07D307/52 , C07D309/32 , C07D317/60 , C07D319/06 , C07D333/08 , C07D333/58 , A61K31/16
-
公开(公告)号:ES2400371T3
公开(公告)日:2013-04-09
申请号:ES06774553
申请日:2006-07-07
Applicant: ABBOTT LAB
Inventor: WENDT MICHAEL , SHEN WANG , DICKMAN DANIEL , DING HONG , THOMAS SHEELA , AUGERI DAVID , ELMORE STEVEN
IPC: A61K31/192 , A61P35/00 , C07C15/12
Abstract: Un compuesto que tiene la fórmula (I), o una sal terapéuticamente aceptable del mismo, en la que A1 es A2, A3 o A4; A2 es alquilo C1-C5, alquenilo C2-C5 o alquinilo C2-C5, estando cada uno de los mismos sustituido con R1; A3 es OL1R1, OL1OR2, NHL1R1 o NHL1NHSO2R2, en los que L1 es alquileno C1-C4 o alquenileno C3-C4; A4 es NHC(O)R1, C(O)NHR1, NHSO2R1 o NHSO2L2R1, en los que L2 es alquileno C1-C3 o alquenileno C2-C3; R1 es R2 o R3; R2 es fenilo que está sin condensar o condensado con benceno, heteroareno o R2A, en el que R2A es cicloalcano; R3 es heteroarilo que está sin condensar o condensado con benceno; B1 es fenilo sustituido con un F; C1 es C2; C2 es C(O)OH; donde R2 y R3 están independientemente sin sustituir o sustituidos con uno, dos, tres, cuatro o cinco de R17, OR17, 15 SR17, S(O)R17SO2R17, C(O)R17, CO(O)R17, OC(O)R17, OC(O)OR17, NH2, NHR17, N(R17)2, NHC(O)R17, C(O)NH2, C(O)NHR17, C(O)N(R17)2, C(O)NHOH, C(O)NHOR17, C(O)NHSO2R17, C(O)NR17, NHSO2R17 N(SO2R17)2, SO2NH2, SO2NHR17, SO2N(R17)2, C(O)H, C(O)OH, C(N)NH2, C(N)NHR17, C(N)N(R17)2, N>=NR17, CNOH, CNOCH3, OH, (O), N3, NO2, CF3, CF2CF3, CF2CI, SO2CF3, SO2CF2CF3, SO2CF2CI, NHSO2CF3, NHSO2CF2CF3, OCF3, OCF2CF3, F, Cl, Br o I sin sustituir o sustituidos, donde R17 es R18, R19, R20 o R21; R18 es fenilo que está sin condensar o condensado con benceno, heteroareno o R18A, donde R18A es cicloalcano, cicloalqueno, heterocicloalcano o heterocicloalqueno; R19 es heteroarilo que está sin condensar o condensado con benceno, heteroareno o R19A, donde R19A es cicloalcano, cicloalqueno, heterocicloalcano o heterocicloalqueno; R20 es cicloalquilo, cicloalquenilo, heterocicloalquilo o heterocicloalquenilo, estando cada uno de los mismos sin condensar o condensado con benceno, heteroareno o R20A, donde R20A es cicloalcano, cicloalqueno, heterocicloalcano o heterocicloalqueno; R21 es alquilo, alquenilo o alquinilo, estando cada uno de los mismos sin sustituir o sustituido con uno o dos de alquilo, alquenilo, alquinilo, R22, OR22, NHR22, SR22, S(O)R22 o SO2R22 seleccionados independientemente; R22 es fenilo, heteroarilo, cicloalquilo, cicloalquenilo, heterocicloalquilo o heterocicloalquenilo, estando cada uno de los mismos sin condensar, o condensado con benceno, heteroareno o R22A, donde R22A es cicloalcano, cicloalqueno, heterocicloalcano o heterocicloalqueno; en el que los restos cíclicos representados por R18, R18A, R19, R19A, R20, R20A, R22 y R22A están independientemente sin sustituir o sustituidos con uno, dos, tres, cuatro o cinco de R23, OR21, NHR23, N (R23)2, SR23, S(O)R23 o SO2R23, CF3, CF2CF3, OH, NH2, NHCH3, N(CH3)2, N3, NO2, CF3, CF2CF3, NHSO2CF3, NHSO2CF2CF3, OCF3, OCF2CF3, F, Cl, Br o I seleccionados independientemente; R23 es fenilo, heteroarilo, cicloalquilo, cicloalquenilo, heterocicloalquilo, heterocicloalquenilo o R24; R24 es alquilo, alquenilo o alquinilo, estando cada uno de los mismos sin sustituir o sustituido con fenilo, heteroarilo, cicloalquilo, cicloalquenilo, heterocicloalquilo o heterocicloalquenilo.
-
公开(公告)号:CA2423103C
公开(公告)日:2010-08-24
申请号:CA2423103
申请日:2001-09-20
Applicant: ABBOTT LAB
Inventor: MCCLELLAN WILLIAM , OOST THORSTEN , BRUNCKO MILAN , WANG XILU , AUGERI DAVID J , BAUMEISTER STEVEN A , DICKMAN DANIEL A , DING HONG , DINGES JURGEN , FESIK STEPHEN W , HAJDUK PHILIP J , KUNZER AARON R , NETTESHEIM DAVID G , PETROS ANDREW M , ROSENBERG SAUL H , SHEN WANG , THOMAS SHEELA A , WENDT MICHAEL D
IPC: C07C311/51 , A61K31/18 , A61K31/428 , A61K31/63 , A61K31/635 , A61P9/10 , A61P25/16 , A61P25/28 , A61P29/00 , A61P31/12 , A61P31/18 , A61P35/00 , A61P37/02 , C07C311/46 , C07C317/28 , C07C323/12 , C07C323/17 , C07C323/25 , C07C323/30 , C07C323/37 , C07C323/43 , C07C323/44 , C07C323/48 , C07C323/58 , C07C323/60 , C07D203/10 , C07D205/04 , C07D205/12 , C07D207/09 , C07D207/24 , C07D207/40 , C07D207/404 , C07D209/08 , C07D209/52 , C07D209/54 , C07D209/96 , C07D211/14 , C07D211/44 , C07D211/70 , C07D211/74 , C07D213/56 , C07D213/61 , C07D213/64 , C07D213/69 , C07D213/70 , C07D213/71 , C07D215/14 , C07D215/22 , C07D215/227 , C07D215/38 , C07D215/48 , C07D217/04 , C07D221/20 , C07D231/12 , C07D233/60 , C07D235/08 , C07D235/26 , C07D241/08 , C07D241/16 , C07D249/04 , C07D263/32 , C07D263/56 , C07D263/58 , C07D277/62 , C07D277/64 , C07D295/13 , C07D295/14 , C07D295/155 , C07D295/16 , C07D295/185 , C07D295/20 , C07D295/205 , C07D295/215 , C07D295/26 , C07D307/14 , C07D317/54 , C07D317/58 , C07D333/28 , C07D333/68 , C07D333/70 , C07D401/06 , C07D401/12 , C07D405/04 , C07D405/06 , C07D417/12 , C07D451/02 , C07D491/107
Abstract: N-Benzoyl arylsulfonamides having the formula (I) are BCL-Xl inhibitors and are useful for promoting apoptosis. Also disclosed are BCL-Xl inhibiting compositions and methods of promoting apoptosis in a mammal.
-
公开(公告)号:UY26942A1
公开(公告)日:2002-04-26
申请号:UY26942
申请日:2001-09-19
Applicant: ABBOTT LAB
Inventor: AUGERI DAVID J , DICKMAN DANIEL A , WANG XILU , MCCLELLAN WILLIAM , FESIK STEPHEN W , NETTESHEIM DAVID G , SHEN WANG , OOST THORSTEN , DING HONG , HAJDUK PHILIP J , PETROS ANDREW M , THOMAS SHEELA A , BRUNCKO MILAN , BAUMEISTE STEVEN A , DINGES JURGEN , KUNZER AARON R , ROSEMBERG SAUL H , WENDT MICHAEL D
IPC: A61K31/18 , A61K31/428 , A61K31/63 , A61K31/635 , A61P9/10 , A61P25/16 , A61P25/28 , A61P29/00 , A61P31/12 , A61P31/18 , A61P35/00 , A61P37/02 , C07C311/46 , C07C311/51 , C07C317/28 , C07C323/12 , C07C323/17 , C07C323/25 , C07C323/30 , C07C323/37 , C07C323/43 , C07C323/44 , C07C323/48 , C07C323/58 , C07C323/60 , C07D203/10 , C07D205/04 , C07D205/12 , C07D207/09 , C07D207/24 , C07D207/40 , C07D207/404 , C07D209/08 , C07D209/52 , C07D209/54 , C07D209/96 , C07D211/14 , C07D211/44 , C07D211/70 , C07D211/74 , C07D213/56 , C07D213/61 , C07D213/64 , C07D213/69 , C07D213/70 , C07D213/71 , C07D215/14 , C07D215/22 , C07D215/227 , C07D215/38 , C07D215/48 , C07D217/04 , C07D221/20 , C07D231/12 , C07D233/60 , C07D235/08 , C07D235/26 , C07D241/08 , C07D241/16 , C07D249/04 , C07D263/32 , C07D263/56 , C07D263/58 , C07D277/62 , C07D277/64 , C07D295/13 , C07D295/155 , C07D295/16 , C07D295/185 , C07D295/20 , C07D295/205 , C07D295/215 , C07D295/26 , C07D307/14 , C07D317/54 , C07D333/28 , C07D333/68 , C07D333/70 , C07D401/06 , C07D401/12 , C07D405/04 , C07D405/06 , C07D417/12 , C07D451/02 , C07D491/107 , C07C311/16 , C07D207/00 , C07D211/00 , C07D307/02 , C07D309/00 , C07D333/02 , C07D335/02
Abstract: Las N - benzoilarilsulfonamidas de la fórmula son inhibidoras de BCL - XI y resultan útiles para promover la apoptosis. Asimismo se revelan composiciones inhibidoras de BCL - XI y métodos para promover la apoptosis en un mamífero.
-
-
-
-
-
-
-
-
-